PharmaReports: Oncology
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
All reports focusing on oncology are featured here with the exception of antibody, immunological or cell therapeutic approaches which are listed on the Cancer Immunotherapy channel.
Showing results 201 - 248 of 248
- Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
- Accelerating Lead Generation: Emerging technologies and strategies
- Innovations in Protein Kinase Therapies: Company pipelines, therapeutic applications and market forecasts
- Commercial Insight: Cytotoxic Therapies - Market growth will slow due to increasing genericization
- Monoclonal Antibodies in Cancer Therapy 2009-2024
- In Vitro Diagnostics Market Analysis 2009-2024
- Monoclonal Antibody Therapeutics 2009-2024
- World Generics Market 2009-2024
- Innovations in Oncology Diagnostics: Technological advances, growth opportunities and future market outlook
- Launching Next Generation Oncology Products: Evolving Strategies in a Payor’s Market
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Global Pharmaceutical Biotech Market 2010-2025
- Pipeline Insight: Breast Cancer - Recent approvals increase pressure on pipeline candidates
- Lung Cancer Therapeutics Market Outlook and Pipeline Analysis
- Pipeline Insight: Biologic Targeted Cancer Therapies - Next generation jostles for market position
- Cancer Therapeutics: Market Insight and R&D Pipeline Analysis
- Therapeutic Vaccines - A far-off promise of greatness
- Non-Hodgkin's Lymphomas Diffuse large B-cell lymphoma and follicular lymphoma
- Molecular Diagnostics in Cancer Testing
- Commercial Insight: Antihormonal Cancer Therapies
- Cancer Pain - Physician survey highlights inadequacies in education and treatment
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
- The Worldwide Market for Cancer Diagnostics - 2010
- The Worldwide Market for Cancer Diagnostics
- The Market for Prescription Dermatological Drugs
- The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
- The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
- The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis
- The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
- Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
- Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
- Innovations in Medical Imaging: Technological advances, growth opportunities and future market outlook
- Biomarkers in Breast Cancer, 2010
- Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
- Oncology Market Leaders – Analyses and Outlook – 2010-2025
- Melanoma - Drug Pipeline Analysis and Market Forecasts to 2015
- Non-Small-Cell Lung Cancer (NSCLC) - Drug Pipeline Analysis and Market Forecasts to 2015
- Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015
- Prostate Cancer - Drug Pipeline Analysis and Market Forecasts to 2015
- Mammography World Markets
- World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)
- Medical Imaging Markets: Molecular Imaging
- The Future of Molecular Diagnostics: Innovative technologies driving market opportunities in personalized medicine
- Pricing and Reimbursement Strategies for Diagnostics: Overcoming reimbursement issues and navigating the regulatory environment
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development